Inventor · disambiguated record
Dilinie Fernando
Also filed as: FERNANDO DILINIE · FERNANDO DILINIE P · FERNANDO DILINIE PRASADHINI
21 granted patents·15 pending applications·90 citations·filing 2002–2024
94Inventor score
Top patents by PatentIndex Score
36 records- 0196US9809579B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2016·Granted Nov 7, 2017·26 cites·26 claims
- 0291US10174007B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2017·Granted Jan 8, 2019·8 cites·12 claims
- 0390US7358263B2Fused bicyclic-substituted amines as histamine-3 receptor ligandsABBOTT LAB·Filed 2006·Granted Apr 15, 2008·11 cites·7 claims
- 0486US7094790B2Fused bicyclic-substituted amines as histamine-3 receptor ligandsABBOTT LAB·Filed 2004·Granted Aug 22, 2006·19 cites·19 claims
- 0585US10988463B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2020·Granted Apr 27, 2021·1 cites·8 claims
- 0685US7902236B2Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereofABBOTT LAB·Filed 2009·Granted Mar 8, 2011·7 cites·6 claims
- 0785US7504520B2Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereofABBOTT LAB·Filed 2006·Granted Mar 17, 2009·7 cites·51 claims
- 0883US10787438B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2020·Granted Sep 29, 2020·1 cites·24 claims
- 0982US12371414B2Methods of treating neurological disordersNEUMORA THERAPEUTICS INC·Filed 2024·Granted Jul 29, 2025·0 cites·6 claims
- 1082US11993580B1Methods of treating neurological disordersNEUMORA THERAPEUTICS INC·Filed 2023·Granted May 28, 2024·0 cites·6 claims
- 1180US8889730B2Indole and indazole compounds that activate AMPKPFIZER·Filed 2013·Granted Nov 18, 2014·5 cites·5 claims
- 1278US7807697B2Fused bicyclic-substituted amines as histamine-3 receptor ligandsABBOTT LAB·Filed 2008·Granted Oct 5, 2010·2 cites·10 claims
- 1376US11634410B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2021·Granted Apr 25, 2023·0 cites·18 claims
- 1469US9394285B2Indole and indazole compounds that activate AMPKPFIZER·Filed 2013·Granted Jul 19, 2016·1 cites·6 claims
- 1569US7932245B2Spirocyclopropyl amides and acids and their therapeutic applicationsABBOTT LAB·Filed 2003·Granted Apr 26, 2011·1 cites·11 claims
- 1665US2024336572A1Substituted indazole propionic acid derivative compounds and uses thereofPFIZER·Filed 2024·Application pending·0 cites
- 1765US2019106412A1Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2018·Application pending·0 cites
- 1862US8609680B22,3-dihydro-1H-inden-1-yl-2,7-diazaspiro[3.5] nonane derivativesBHATTACHARYA SAMIT K·Filed 2011·Granted Dec 17, 2013·1 cites·13 claims
- 1962US2025236608A1Egfr inhibitorsBLUEPRINT MEDICINES CORP·Filed 2023·Application pending·0 cites
- 2059US2023019732A1Egfr inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 2157US7956195B2Process for the preparation and isolation of the individual stereoisomers of 1-amino, 3-substituted phenylcyclopentane-carboxylatesABBOTT LAB·Filed 2007·Granted Jun 7, 2011·0 cites·4 claims
- 2256US2012108637A1Fused Bicyclic-Substituted Amines as Histamine-3 Receptor LigandsCOWART MARLON D·Filed 2011·Application pending·0 cites
- 2354US7847104B2Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype1 (VR1) receptorsABBOTT LAB·Filed 2007·Granted Dec 7, 2010·0 cites·29 claims
- 2453US8106088B2Fused bicyclic-substituted amines as histamine-3 receptor ligandsCOWART MARLON D·Filed 2010·Granted Jan 31, 2012·0 cites·12 claims
- 2553US2004209859A1Fused cycloalkyl amides and acids and their therapeutic applicationsFiled 2003·Application pending·0 cites
- 2651US11325909B2Crystalline 2-amino-2-(hydroxymethyl)propane-1,3-diol salt of 4-(4-(1-isopropyl-7-OXO-1,4,6,7-tetrahydrospiro[indazole-5,4′-piperidine]-1′-carbonyl)-6-methoxypryridin-2-YL)benzoic acidPFIZER·Filed 2018·Granted May 10, 2022·0 cites·11 claims
- 2751US2015038484A1Indole and indazole compounds that activate ampkPFIZER·Filed 2014·Application pending·0 cites
- 2850US2011144057A1Antagonists of the vanilloid receptor subtype 1 (vr1) and use thereofABBOTT LAB·Filed 2011·Application pending·0 cites
- 2950US2022387402A1Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseasesPFIZER·Filed 2020·Application pending·0 cites
- 3050US2014080756A12,3-dihydro-1h-inden-1-yl-2,7-diazaspiro[3.5]nonane derivativesPFIZER·Filed 2013·Application pending·0 cites
- 3150US2004224953A1Fused bicyclic-substituted amines as histamine-3 receptor ligandsFiled 2003·Application pending·0 cites
- 3249US2004224952A1Fused bicyclic-substituted amines as histamine-3 receptor ligandsFiled 2003·Application pending·0 cites
- 3345US8519186B2Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype 1 (VR1) receptorsLUKIN KIRILL A·Filed 2010·Granted Aug 27, 2013·0 cites·2 claims
- 3442US2004077617A1Fused cycloalkyl amides and acids and their therapeutic applicationsFiled 2002·Application pending·0 cites
- 3537US2004077616A1Spirocyclopropyl amides and acids and their therapeutic applicationsFiled 2002·Application pending·0 cites
- 3635US2002128496A1Process for the preparation of matrix metalloproteinase inhibitorsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dilinie Fernando files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →